Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

NCT06490328 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: DKF-MA102

Sponsor

Dongkook Pharmaceutical Co., Ltd.